Chesapeake Asset Management’s AstraZeneca AZN Stock Holding History

Chesapeake Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.01K	Buy	+37	New	+$6.96K	0.01%	263
2023 Q3	–	Sell	-179	Closed	-$25.7K	–	445
2023 Q2	$25.7K	Hold	179	–	–	0.02%	170
2023 Q1	$24.9K	Buy	+179	New	+$24.1K	0.02%	172

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Chesapeake Asset Management's AZN Position: Q2 2026 in Review

Chesapeake Asset Management opened a new position in AstraZeneca (AZN) in Q2 2026: 37 shares worth $7.01K. The stake represents 0.01% of the portfolio and ranks #263 among its holdings. This is a return to the name: Chesapeake Asset Management previously reported a position in AZN as recently as Q2 2023.

Chesapeake Asset Management first reported a position in AZN in Q1 2023 and has held it in 3 quarters since. The position peaked at $25.7K in Q2 2023. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Chesapeake Asset Management held 37 shares of AstraZeneca worth $7.01K as of Q2 2026.
AstraZeneca was a new Chesapeake Asset Management position in Q2 2026.
AstraZeneca made up 0.01% of Chesapeake Asset Management's portfolio in Q2 2026, its #263 holding.
Chesapeake Asset Management first reported a position in AstraZeneca in Q1 2023 and has held it in 3 quarters since.
Chesapeake Asset Management's AstraZeneca position peaked at $25.7K in Q2 2023.
1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.